Total Debt Summary of DV Biomed Co., Ltd.

DV Biomed Co., Ltd.'s latest annual total debt in 2023 was 387.69 Million TWD , down -16.9% from previous year.
DV Biomed Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 25.96 Million TWD , down 0.0% from previous quarter.
DV Biomed Co., Ltd. reported annual total debt of 466.52 Million TWD in 2022, up 108.19% from previous year.
DV Biomed Co., Ltd. reported annual total debt of 224.09 Million TWD in 2021, down -10.39% from previous year.
DV Biomed Co., Ltd. reported quarterly total debt of 25.96 Million TWD for 2024 Q1, down -93.3% from previous quarter.
DV Biomed Co., Ltd. reported quarterly total debt of 387.69 Million TWD for 2023 Q4, up 22.79% from previous quarter.

Annual Total Debt Chart of DV Biomed Co., Ltd. (2023 - 2019)

Name	Total Debt	Total Debt Difference
Allied Biotech Corporation	796.6 Million TWD	51.332%
GeneFerm Biotechnology Co., Ltd.	152.07 Million TWD	-154.931%
Easywell Biomedicals, Inc.	386.34 Million TWD	-0.35%
TTY Biopharm Company Limited	1.91 Billion TWD	79.755%
Synmosa Biopharma Corporation	2.43 Billion TWD	84.11%
Orient EuroPharma Co., Ltd.	4.84 Billion TWD	91.994%
Center Laboratories, Inc.	5.62 Billion TWD	93.106%
Tien Liang BioTech Co., Ltd.	84.65 Million TWD	-357.95%
Orient Pharma Co., Ltd.	716.92 Million TWD	45.923%
InnoPharmax Inc.	21.49 Million TWD	-1703.321%
Johnson Chemical Pharmaceutical Works Co., Ltd.	160.83 Million TWD	-141.058%
Excelsior Biopharma Inc.	377.4 Million TWD	-2.727%
Foresee Pharmaceuticals Co., Ltd.	228.25 Million TWD	-69.851%
Handa Pharmaceuticals, Inc.	13.24 Million TWD	-2828.218%
UniPharma Co., Ltd.	277 Thousand TWD	-139862.455%
Anxo Pharmaceutical Co., Ltd.	787.84 Million TWD	50.79%
Alar Pharmaceuticals Inc.	1.4 Million TWD	-27415.685%
Winston Medical Supply Co., Ltd.	107.32 Million TWD	-261.222%
Mercury Biopharmaceutical Corporation	42.34 Million TWD	-815.479%
Bioray Biotech Co., Ltd	69.79 Million TWD	-455.502%
TSH Biopharm Corporation Limited	7.84 Million TWD	-4843.211%